Shawna Kraft

University of Michigan–Ann Arbor — United States

Medicine · Health Sciences

8h-index229citations23works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(5), Cancer Treatment and Pharmacology(3), Nausea and vomiting management(3), Pharmaceutical studies and practices(3), Safe Handling of Antineoplastic Drugs(3)

Publications23 total

Approaches to management of endocrine therapy–induced alopecia in breast cancer patients
Supportive Care in Cancer·2025· 1 cited
Characterizing access for oral oncolytics used to treat breast cancer at an academic medical center.
JCO Oncology Practice·2024
Abstract PS14-02: Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522
Cancer Research·2024· 2 cited
Abstract PS14-06: Real-World Analysis of Adverse Events in Patients with Triple Negative Breast Cancer Receiving Therapy per KEYNOTE-522
Cancer Research·2024· 2 cited
Comparing Modes of Cancer Drug Safety Training for Multiprofessional Learners: A Roadmap for Adapting from In-Person to Distance Simulation
Journal of Interactive Learning Research·2023
Ipilimumab Dosing and Clinical Efficacy in Solid Tumors: A Retrospective Analysis
SSRN Electronic Journal·2023Open Access
Cancer Drug Safety Training: Comparing Distance and In-Person Simulations for Interprofessional Education.
PubMed·2023Open Access
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer
The Journal of Urology·2022· 5 cited
Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
Frontiers in Oncology·2022· 6 citedOpen Access
Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management
Supportive Care in Cancer·2021· 17 cited
Opportunities for pharmacists to impact student health on college campuses
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY·2021· 12 citedOpen Access
Evaluation of an Interprofessional Training Program to Improve Cancer Drug Therapy Safety
JCO Oncology Practice·2021· 16 citedOpen Access
Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting
JCO Oncology Practice·2021· 19 citedOpen Access
Chemotherapy remote care monitoring program (CRCMP): Integration of an SMS text patient-reported outcome (PRO) in the electronic health record (EHR) to identify patients needing pharmacist intervention for chemotherapy-induced nausea and vomiting (CINV).
Journal of Clinical Oncology·2020
Toxicities with combination BRAF and MEK inhibition in resected stage III melanoma.
Journal of Clinical Oncology·2020
Mothers in academic pharmacy
Currents in Pharmacy Teaching and Learning·2018· 5 cited
Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics
Journal of Oncology Practice·2018· 46 citedOpen Access
Evaluation of outpatient medication reconciliation involving student pharmacists at a comprehensive cancer center
Journal of the American Pharmacists Association·2015· 26 cited
8:35 Palliative Care for Older Adults: Creating an "Extra Layer" of Interdisciplinary Support
2015
Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity
Psycho-Oncology·2013· 11 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Emily Mackler(3), Shannon Hough(3), Rachel L McDevitt(3), Victoria Nachar(3), Anna M. Brown(3), Catherine Christen(3), Morgan J. Homan(3), Michelle Aebersold(3), Karen B. Farris(3), Marylee Scherdt(3), MiKaela Olsen(3), Martha Polovich(3), Brenda K. Shelton(3), Guy H. Montgomery(3), Christopher R. Friese(3), Jolene R. Bostwick(3), Christopher D. Lao(3), Sarah Yentz(3), Leslie A. Fecher(3), Peter Schlickman(2)